A Network Comparison on Efficacy and Safety Profiling of PD-1/PD-L1 Inhibitors in First-Line Treatment of Advanced Non-Small Cell Lung Cancer
FRONTIERS IN PHARMACOLOGY（2025）
Key words
programmed death-ligand 1,non-small cell lung cancer,immune checkpoint inhibitors,PD-1/PD-L1 inhibitors,network meta-analysis
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined